Mar 19, 2020
Multiple Sclerosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2019 to 2027)
Mar 12, 2020
n-Lorem Foundation receives additional support for providing "n of 1" experimental antisense medicines to treat patients with ultra-rare diseases
Feb 27, 2020
Ionis Pharmaceuticals to present at upcoming investor conferences
Feb 26, 2020
Ionis provides fourth quarter and full year 2019 financial results
Feb 11, 2020
Overall Share of Ocrevus Remains Stable Among Recent New Start Patients, Yet Genentech's Efforts to Increase First-Line Use Appears to be Paying Off in the Dominant Relapsing-Remitting Multiple Sclerosis Subgroup
Feb 03, 2020
PTC Therapeutics to Host A Conference Call to Review Part 2 of the SUNFISH Clinical Trial Data at the SMA Europe Conference
Jan 30, 2020
The global gene therapy market is projected to reach USD 13.0 billion by 2024 from USD 3.8 billion in 2019, at a CAGR of 27.8%
Jan 22, 2020
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx
Jan 13, 2020
PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference
Jan 09, 2020
Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer
Jan 08, 2020
n-Lorem Foundation established to charitably provide antisense medicines to treat patients with ultra-rare diseases
Dec 19, 2019
Cygnal Appoints Elaine Caughey as Chief Business Officer
Dec 02, 2019
Ionis Pharmaceuticals to hold technology webcast
Nov 12, 2019
Alkermes Announces Receipt of $150 Million Milestone Payment from Biogen Related to FDA Approval of VUMERITY(TM)
Nov 11, 2019
Risdiplam (RG7916) Pivotal SUNFISH Study Demonstrates Statistically Significant Improvement for Patients with Type 2/3 Spinal Muscular Atrophy
Nov 06, 2019
Ionis provides third quarter financial results and improved 2019 guidance
Oct 28, 2019
Bench to bedside strategies demonstrate Ionis' foremost expertise in RNA-targeted therapeutics at DIA/FDA Oligonucleotide Conference
Oct 23, 2019
Ionis Chairman and CEO Stanley T. Crooke, M.D., Ph.D. to receive Massry Prize for contributions to biomedical sciences
Oct 22, 2019
Ionis Pharmaceuticals to hold third quarter 2019 financial results webcast
Oct 16, 2019
Neurimmune and TVM Capital Life Science Announce the Initiation of AL-S Pharma's Phase 1 Study of AP-101 for the Treatment of ALS